Integrin avb3 and fibronectin upregulate slug in cancer cells to promote clot invasion and metastasis

Cancer Research

Volumn 73, Issue 20, 2013, Pages 6175-6184

  Knowles, Lynn M ^a   Gurski, Lisa A ^a   Engel, Charlotte ^a   Gnarra, James R ^a,b   Maranchie, Jodi K ^a,b   Pilch, Jan ^a,b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; BETA3 INTEGRIN; FIBRIN; FIBRONECTIN; HIRUDIN; MATRIGEL; NERVE CELL ADHESION MOLECULE; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR TWIST; TRANSFORMING GROWTH FACTOR BETA; UVOMORULIN; VIMENTIN; VITRONECTIN RECEPTOR; SNAIL FAMILY TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN BINDING; ARTICLE; BLOOD CLOT; BLOOD CLOTTING; BLOOD CLOTTING PARAMETERS; CANCER CELL; CELLULAR PARAMETERS; CLOT INVASION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENE SILENCING; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; INVADOPODIA; KIDNEY CARCINOMA; LUNG METASTASIS; MALE; MOUSE; NONHUMAN; PHASE CONTRAST MICROSCOPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SINGLE DRUG DOSE; SOFT TISSUE SARCOMA; STRESS FIBER; TUMOR VOLUME; UPREGULATION; ANIMAL; BLOOD; CELL ADHESION; CONFOCAL MICROSCOPY; GENETICS; METABOLISM; METASTASIS; NEOPLASM; NUDE MOUSE; PATHOLOGY; THROMBOSIS; TUMOR CELL LINE; TUMOR INVASION;

ANIMALS; CELL ADHESION; CELL LINE, TUMOR; FEMALE; FIBRONECTINS; GENE SILENCING; HUMANS; INTEGRIN ALPHAVBETA3; MALE; MICE, NUDE; MICROSCOPY, CONFOCAL; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS; THROMBOSIS; TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 84886044680     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-13-0602     Document Type: Article

References (49)

1. Chaffer CL, Weinberg RA A perspective on cancer cell metastasis. Science 2011; 331:1559-64.
2. Sun M, Lughezzani G, Perrotte P., Karakiewicz PI Treatment of metastatic renal cell carcinoma. Nat Rev Urol 2010; 7:327-38.
3. Karam JA, Rini BI, Varella L, Garcia J.A., Dreicer R., Choueiri TK, et al Metastasectomy after targeted therapy in patients with advanced renal cell carcinoma. J Urol 2011; 185:439-44.
4. Gorelik E, Bere WW, Herberman RB Role of NK cells in the antimetastatic effect of anticoagulant drugs. Int J Cancer 1984; 33: 87-94.
5. Malik G, Knowles LM, Dhir R, Xu S., Yang S, Ruoslahti E, et al Plasma fibronectin promotes lung metastasis by contributions to fibrin clots and tumor cell invasion. Cancer Res 2010; 70: 4327-34.
6. Liu J, Tan Y, Zhang H., Zhang Y, Xu P, Chen J., et al Soft fibrin gels promote selection and growth of tumorigenic cells. Nat Mater 2012; 11:734-41.
7. Palumbo JS, Talmage KE, Massari J.V., La Jeunesse CM, Flick MJ, Kombrinck KW, et al Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells. Blood 2005; 105:178-85.
8. Esumi N, Fan D, Fidler IJ Inhibition of murine melanoma experimental metastasis by recombinant desulfatohirudin, a highly specific thrombin inhibitor. Cancer Res 1991; 51:4549-56.
9. Gupta GP, Massague J. Cancer metastasis: building a framework. Cell 2006; 127:679-95.
10. Thiery JP, Sleeman JP Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 2006; 7:131-42.
11. Wang Y, Ngo VN, Marani M, Yang Y., Wright G, Staudt LM, et al Critical role for transcriptional repressor Snail2 in transformation by oncogenic RAS in colorectal carcinoma cells. Oncogene 2010; 29:4658-70.
12. Yang MH, Wu MZ, Chiou S.H., Chen PM, Chang SY, Liu CJ, et al Direct regulation of TWIST by HIF-1alpha promotes metastasis. Nat Cell Biol 2008; 10:295-305.
13. Wu ZQ, Li XY, Hu C.Y., Ford M., Kleer CG, Weiss SJ Canonical Wnt signaling regulates Slug activity and links epithelial-mesenchymal transition with epigenetic Breast Cancer 1, Early Onset (BRCA1) repression. Proc Natl Acad Sci U S A 2012; 109:16654-9.
14. Bhowmick NA, Ghiassi M, Bakin A., Aakre M, Lundquist CA, Engel M.E., et al Transforming growth factor-beta1 mediates epithelial to mesenchymal trans differentiation through a RhoA-dependent mechanism. Mol Biol Cell 2001; 12:27-36.
15. Avizienyte E, Wyke AW, Jones R.J., McLean GW, Westhoff MA, Brunton VG, et al Src-induced de-regulation of E-cadherin in colon cancer cells requires integrin signalling. Nat Cell Biol 2002; 4:632-8.
16. Felding-Habermann B., Lerner RA, Lillo A, Zhuang S., Weber MR, Arrues S, et al Combinatorial antibody libraries from cancer patients yield ligand-mimetic Arg-Gly-Asp-containing immunoglobulins that inhibit breast cancer metastasis. Proc Natl Acad Sci U S A 2004; 101:17210-5.
17. Natali PG, Hamby CV, Felding-Habermann B, Liang B., Nicotra MR, Di Filippo F, et al Clinical significance of alpha(v)beta3 integrin and intercellular adhesion molecule-1 expression in cutaneous malignant melanoma lesions. Cancer Res 1997; 57:1554-60.
18. Desgrosellier JS, Barnes LA, Shields D.J., Huang M., Lau SK, Prevost N, et al An integrin alpha(v)beta(3)-c-Src oncogenic unit promotes anchorage-independence and tumor progression. Nat Med 2009; 15: 1163-9.
19. Humphries MJ, Olden K, Yamada KM A synthetic peptide from fibronectin inhibits experimental metastasis of murine melanoma cells. Science 1986; 233:467-70.
20. Felding-Habermann B., O'Toole TE, Smith JW, Fransvea E, Ruggeri Z.M., Ginsberg MH, et al Integrin activation controls metastasis in human breast cancer. Proc Natl Acad Sci U S A 2001; 98:1853-8.
21. Pilch J, Habermann R, Felding-Habermann B. Unique ability of integrin alpha(v)beta 3 to support tumor cell arrest under dynamic flow conditions. J Biol Chem 2002; 277:21930-8.
22. Pampori N, Hato T, Stupack D.G., Aidoudi S., Cheresh DA, Nemerow GR, et al Mechanisms and consequences of affinity modulation of integrin alpha(V)beta(3) detected with a novel patch-engineered monovalent ligand. J Biol Chem 1999; 274:21609-16.
23. Mueller BM, Reisfeld RA, Edgington T.S., Ruf W. Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis. Proc Natl Acad Sci U S A 1992; 89:11832-6.
24. Wu C, Keivens VM, O'Toole TE, McDonald JA, Ginsberg MH Integrin activation and cytoskeletal interaction are essential for the assembly of a fibronectin matrix. Cell 1995; 83:715-24.
25. Hess KR, Varadhachary GR, Taylor S.H., Wei W., Raber MN, Lenzi R, et al Metastatic patterns in adenocarcinoma. Cancer 2006; 106:1624-33.
26. Huth JF, Eilber FR Patterns of metastatic spread following resection of extremity soft-tissue sarcomas and strategies for treatment. Semin Surg Oncol 1988; 4:20-6.
27. Sarin H. Physiologic upper limits ofpore size of different blood capillary types and another perspective on the dual pore theory of microvascular permeability. J Angiogenes Res 2010; 2:14.
28. Walker DC, MacKenzie A, Hosford S. The structure of the tricellular region of endothelial tight junctions of pulmonary capillaries analyzed by freeze-fracture. Microvasc Res 1994; 48:259-81.
29. Padua D, Zhang XH, Wang Q, Nadal C., Gerald WL, Gomis RR, et al TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4. Cell 2008; 133:66-77.
30. Im JH, Fu W, Wang H., Bhatia SK, Hammer DA, Kowalska MA, et al Coagulation facilitates tumor cell spreading in the pulmonary vasculature during early metastatic colony formation. Cancer Res 2004; 64: 8613-9.
31. Labelle M, Begum S, Hynes RO Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell 2011; 20:576-90.
32. Boreddy SR, Srivastava SK Deguelin suppresses pancreatic tumor growth and metastasis by inhibiting epithelial-to-mesenchymal transition in an orthotopic model. Oncogene 2012; 32:3980-91.
33. Minn AJ, Gupta GP, Siegel P.M., Bos PD, Shu W, Giri DD, et al Genesthat mediate breast cancer metastasis to lung. Nature 2005; 436:518-24.
34. Bailey CL, Kelly P, Casey PJ Activation of Rap1 promotes prostate cancer metastasis. Cancer Res 2009; 69:4962-8.
35. Clark EA, Golub TR, Lander E.S., Hynes RO Genomic analysis of metastasis reveals an essential role for Rho C. Nature 2000; 406:532-5.
36. Yao ES, Zhang H, Chen Y.Y., Lee B., Chew K, Moore D, et al Increased beta1 integrin is associated with decreased survival in invasive breast cancer. Cancer Res 2007; 67:659-64.
37. Mehrotra S, Languino LR, Raskett C.M., Mercurio AM, Dohi T, Altieri DC IAP regulation of metastasis. Cancer Cell 2010; 17:53-64.
38. Yu M, Bardia A, Wittner B.S., Stott SL, Smas ME, Ting DT, et al Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 2013; 339:580-4.
39. Brenner KA, Corbett SA, Schwarzbauer JE Regulation of fibronectin matrix assembly by activated Ras in transformed cells. Oncogene 2000; 19:3156-63.
40. Barkan D, Kleinman H, Simmons J.L., Asmussen H., Kamaraju AK, Hoenorhoff MJ, et al Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton. Cancer Res 2008; 68:6241-50.
41. Cheng JC, Chang HM, Leung PC Egr-1 mediates epidermal growth factor-induced downregulation of E-cadherin expression via Slug in human ovarian cancer cells. Oncogene 2013; 32:1041-9.
42. Shih JY, Tsai MF, Chang T.H., Chang YL, Yuan A, Yu CJ, et al Transcription repressor slug promotes carcinoma invasion and predicts outcome of patients with lung adenocarcinoma. Clin Cancer Res 2005; 11:8070-8.
43. Laird A, O'Mahony FC, Nanda J, Riddick A.C., O'Donnell M, Harrison DJ, et al Differential expression of prognostic proteomic markers in primary tumour, venous tumour thrombus and metastatic renal cell cancer tissue and correlation with patient outcome. PLoS ONE 2013; 8: e60483.
44. O'Mahony F.C., Faratian D, Varley J., Nanda J, Theodoulou M, Riddick A.C., et al The use of automated quantitative analysis to evaluate epithelial-to-mesenchymal transition associated proteins in clear cell renal cell carcinoma. PLoS ONE 2012; 7:e31557.
45. Oakes PW, Beckham Y, Stricker J., Gardel ML Tension is required but not sufficient for focal adhesion maturation without a stress fiber template. J Cell Biol 2012; 196:363-74.
46. Kumper S, Marshall CJ ROCK-driven actomyosin contractility induces tissue stiffness and tumor growth. Cancer Cell 2011; 19: 695-7.
47. Conacci-Sorrell M., Simcha I, Ben-Yedidia T, Blechman J., Savagner P, Ben-Ze'ev A. Autoregulation of E-cadherin expression by cadherincadherin interactions: the roles of beta-catenin signaling, Slug, and MAPK. J Cell Biol 2003; 163:847-57.
48. Zeng Q, Li W, Lu D., Wu Z, Duan H, Luo Y., et al CD146, an epithelial-mesenchymal transition inducer, is associated with triple-negative breast cancer. Proc Natl Acad Sci U S A 2012; 109:1127-32.
49. Dubash AD, Wennerberg K, Garcia-Mata R, Menold M.M., Arthur WT, Burridge K. A novel role for Lsc/p115 RhoGEF and LARG in regulating RhoA activity downstream of adhesion to fibronectin. J Cell Sci 2007; 120:3989-98.